| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ORAGENICS INC | CEO and President, Director | Common Stock | 25K | $89.2K | $3.57 | Aug 8, 2023 | Direct |
| Blue Water Vaccines Inc. | Director | Stock Option | 50.6K | May 4, 2022 | Direct | ||
| Clarus Therapeutics Holdings, Inc. | Director | Common Stock | 5.77K | Jun 7, 2022 | Direct | ||
| Clarus Therapeutics Holdings, Inc. | Director | Stock Option (Right to Buy) | 4.81K | Jun 7, 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| OGEN | ORAGENICS INC | Aug 8, 2023 | 1 | $0 | 4 | Aug 10, 2023 | CEO and President, Director |
| OGEN | ORAGENICS INC | Jun 23, 2022 | 1 | $0 | 4 | Jun 24, 2022 | CEO and President, Director |
| CRXT | Clarus Therapeutics Holdings, Inc. | Jun 7, 2022 | 2 | $0 | 4 | Jun 9, 2022 | Director |
| BWV | Blue Water Vaccines Inc. | May 4, 2022 | 1 | $0 | 4 | May 27, 2022 | Director |
| BWV | Blue Water Vaccines Inc. | Feb 17, 2022 | 0 | $0 | 3 | Feb 17, 2022 | Director |
| OGEN | ORAGENICS INC | Dec 16, 2021 | 1 | $0 | 4 | Dec 20, 2021 | Director |
| CRXT | Clarus Therapeutics Holdings, Inc. | Dec 12, 2021 | 2 | $0 | 4 | Dec 14, 2021 | Director |